Goodwin Procter and Latham & Watkins acted as legal advisor to TA, while Paul Hastings acted as legal advisor to Francisco Partners on the deal. TA...
TA Associates and Francisco Partners’ Investment in Orisha
Illumina’s Divestiture of GRAIL
Cravath, Swaine & Moore represented Illumina, Inc. on the transaction, and Latham & Watkins represented GRAIL, LLC. GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC), a healthcare...
Vapotherm’s Merger and Take-Private
Ropes & Gray acted as legal counsel to Vapotherm, Inc. in the transaction. Cooley acted as legal counsel to Perceptive and Latham & Watkins acted as...
Gilead’s $2 Billion Senior Unsecured Notes Offering
Davis Polk advised Gilead, and Latham & Watkins advised the underwriters. Gilead Sciences, Inc. (Nasdaq: GILD) announced the pricing of senior unsecured notes in an aggregate...
Korro Bio and Frequency Therapeutics’ Merger Agreement
Goodwin Procter is serving as legal counsel to Korro Bio, Latham & Watkins is serving as Frequency Therapeutics’ legal counsel, and Davis Polk is serving as...
Ironwood Pharmaceuticals’ $1 Billion Acquisition of VectivBio Holding
Advestra and Latham & Watkins advise Ironwood. Homburger AG serves as legal and tax advisor to VectivBio on the transaction. Goodwin advises Centerview Partners. VectivBio Holding...
Natus’ Acquisition of Micromed Holding SAS
Latham & Watkins LLP represented ArchiMed and Natus in the transaction. Natus Medical Incorporated (Natus), a leading provider of medical device solutions, has announced the closing...
Cordis’ Acquisition of MedAlliance
Latham & Watkins represented MedAlliance in the transaction. Swiss-based medical technology company MedAlliance announced it has entered into an agreement with Cordis for an acquisition which includes...
Nordic Capital’s Investment Into Equashield
Latham & Watkins LLP represented Nordic Capital in the transaction. Nordic Capital, a leading private equity investor, and Equashield have announced that Nordic Capital has joined Equashield’s...
MeiraGTx’s Growth Financing Agreement with Perceptive Advisors
Latham & Watkins represented MeiraGTx in the transaction. MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage gene therapy company, announced a financing agreement with affiliates...
Amgen’s $3.7 Billion Acquisition of ChemoCentryx
Wachtell, Lipton, Rosen & Katz represented Amgen, while Latham & Watkins represented ChemoCentryx in the transaction. Amgen and ChemoCentryx, Inc., a biopharmaceutical company focused on orally...
BC Partners’ Acquisition of Havea
Latham & Watkins advised BC Partners. Jeausserand Audouard advised Havea Group. Kirkland & Ellis advised Funds advised by BC Partners on the financing of the acquisition....